Camargo Pharmaceutical Services in the News

Below are spotlights of some of the awards, recognitions, and press that Camargo receives for their industry-leading research and strategies in the 505(b)(2) space.

Camargo Pharmaceutical Services To Expand Capabilities And Enhance  Global Presence –  Cincinnati, OH, February 26, 2019

Cellix Biosciences Announces Regulatory Pathway Confirmation for CLX-106 in the U.S. at BusinessWire, July 11, 2018

Camargo Congratulates US WorldMeds on Obtaining FDA Approval for the First Non-Opioid Medicine for the Management of Opioid Withdrawal Symptoms at PRNewswire, July 9, 2018

Camargo Celebrates Fifteen Years at PRNewswire, June 1, 2018

Aequus Receives Positive FDA Regulatory Guidance for Anti-Nausea Patch at Globe Newswire, May 3, 2018

Daniel S. Duffy – Appointed New CEO of Camargo Pharmaceutical Services, LLC at PR Newswire, April 30, 2018

Aequus and Camargo Complete Pre-Investigational New Drug Submission with FDA for Transdermal Anti-Nausea Program at GlobeNewswire, April 17, 2018

V ClinBio Partners with Camargo for Strategic 505(b)(2) Development of Transformative Prodrug Technology Platform at PRNewswire, March 6, 2018

Aequus and Camargo Prepare for Meeting with FDA to Advance Anti-Nausea Patch at MarketWired, January 31, 2018

Article: Camargo, Ken Phelps, and 505(b)(2) in Korean publications, December 11, 2017

Veru Acquires Novel Proprietary Formulation for Overactive Bladder at Globe Newswire

December 13, 2017

Camargo CEO Meeting with Leading Companies in Japan, Korea, Taiwan, and India at PR Newswire

December 4, 2017

Veru Announces Tamsulosin DRS Bioequivalence Clinical Trial Results at Globe Newswire

November 13, 2017

Callitas Announces Positive FDA Response to Extrinsa Pre-IND Submission at AccessWire

October 11, 2017

Lumosa Therapeutics Partners with Camargo Pharmaceutical Services in the Development of Naldebain(R) in the US at Business Insider

August 28, 2017

Aequus Announces Abbreviated Development Path for Transdermal Aripiprazole at Business Insider

August 24, 2017

Global Health Solutions Partners with Camargo Pharmaceutical Services for Onychomycosis Development Program at BizJournals

August 21, 2017

Cingulate Therapeutics Partners with Camargo Pharmaceutical Services for Development Programs at PRNewswire

August 8, 2017

Quivive Pharma Partners with Camargo Pharmaceutical Services for Development Programs at PRNewswire

May 4, 2017

Camargo Pharmaceutical Services Partners with Private Investment Firm at PRNewswire

March 16, 2017

Impel NeuroPharma Partners with Camargo Pharmaceutical Services for Development Programs at PRNewswire

February 7, 2017

Cocoon Biotech Announces Partnership with Camargo Pharmaceutical Services for Development Programs at PRNewswire

February 2, 2017

How Many FDA Premarket Applications Are Necessary For Your Combination Product? at Pharmaceutical Online, Med Device Online, and Bio Process Online

October 25, 2016

M Pharmaceutical Inc. Engages Camargo Pharmaceutical Services To Develop Regulatory Strategy For Newly Acquired Chelatexx Technology at Clinical Leader

October 11, 2016

Aequus Partners With Camargo to Support US Regulatory Strategy for Development Programs at Market Wired

Monday, October 3, 2016

Camargo Pharmaceutical Services Adds to Medical Device Expertise at PR Newswire

Tuesday, September 27, 2016

Camargo Pharmaceutical Services Grows, Adds Three Drug Development Experts at Newswire

Wednesday, August 10, 2016

Expanded Access: Is It Compassionate Use for Patients? at AAPS

Monday, July 27, 2016

India’s Drugmakers Step Up U.S. Involvement, as quoted in the Wall Street Journal, article by Suryatapa Bhattacharya

Wednesday, February 24, 2016

A Primer On The 505(b)(2) Pathway For Combination Drug/Device Products at Pharmaceutical Online

Tuesday, February 16, 2016

Camargo Pharmaceutical Services Integral in Medicines360’s Intrauterine Contraceptive Device FDA Approval

Tuesday, January 19, 2016

2nd Annual 505(b)(2) Forum To Discuss Product Development, Regulatory Updates And Recent Court Cases

Thursday, October 22, 2015

Camargo Pharmaceutical Services And FDA To Share 505(b)(2) Expertise At 2015 AAPS Annual Meeting And Exposition
Wednesday, October 14, 2015

Camargo Welcomes Postdoctoral Interns To Its Durham, N.C., Office
Tuesday, August 04, 2015

Partnership With University Of Cincinnati Provides Postdoctoral Interns Hands-On Experience At Camargo
Tuesday, July 21, 2015

Camargo Adds Extensive Scientific, Regulatory And Legal Affairs Experience To Team
Tuesday, June 16, 2015

The 505(b)(2) Forum In Israel Will Review Case Studies And Strategies For 505(b)(2) Approval Pathway
Tuesday, April 14, 2015

Camargo Pharmaceutical Services Prepares For Growth/ Names Jason Moore Vice President Of Global Program Management
Thursday, March 12, 2015

Camargo Pharmaceutical Services Names Carter Gaither Chief Financial Officer
Thursday, February 12, 2015

Camargo Launches New Brand At GPHA As 505(b)(2) Development Continues Upward Trend
Wednesday, February 04, 2015

Israel Seminar Highlights Best Strategies For Developing New Products In Growing Market
Thursday, December 11, 2014

Camargo Meets Growing Client Needs With Appointment Of Industry Leader Steven Castillo As Vice President Of Drug Development
Wednesday, October 29, 2014

The 505(b)(2) Forum To Feature Successful Methodologies And Technology Approaches
Tuesday, October 14, 2014

Camargo Strengthens Research Team And Therapeutic Expertise
Wednesday, July 23, 2014

Elite Pharmaceuticals Initiates Pivotal Bioequivalence Study For Eli-201
Tuesday, July 15, 2014

The Right Path
Thursday, July 03, 2014

Elite Pharmaceuticals Begins Human Abuse Liability Studies For Eli-200
Monday, June 09, 2014

Foreign Trips Sell Cincinnati To Overseas Businesses
Monday, May 19, 2014

Internship Program Offers Opportunities For Postdoctoral Researchers And Camargo
Thursday, March 27, 2014

U.S. Generics: FDA Policy Changes/ Growing Use Of 505b2/ And Supply Shortages; Topics From A Roundtable Discussion
Monday, March 17, 2014

Olu Aloba Joins Camargo Pharmaceutical Services As Senior Director Of Pharmaceutics
Tuesday, March 11, 2014

CEOs Say 505(b)(2) Pathway Will Drive Growth In Generic Industry
Thursday, February 27, 2014

Camargo’s Ready 4 Action Assessment Helps Generic Drug Companies Overcome The Patent Cliff
Wednesday, February 05, 2014

Camargo Invests In High-Level It System To Increase Accessibility And Preserve Client Data
Thursday, January 30, 2014

Elite Pharmaceuticals Initiates Pivotal Bioequivalence Study For Second Opioid Abuse Deterrent Product
Tuesday, January 14, 2014

Israeli Drug Development Companies Are Poised For 505(b)(2) Development Process, Camargo Expert Says
Tuesday, December 17, 2013

Elite Pharmaceuticals Initiates Pilot Bioequivalence Study For Eli-201
Thursday, December 05, 2013

Camargo Pharmaceutical Services Names Jim Beach Chief Operating Officer
Wednesday, November 20, 2013

Bioohio President Discusses Ohio’s Biotechnology Industry
Wednesday, November 06, 2013

Camargo Celebrates 10 Years With The 505(b)(2) Pathway
Thursday, October 24, 2013

Generic Companies Look To The 505(b)(2) Application Process To Speed Up Product Approvals
Tuesday, September 24, 2013

505(b)(2) Applications: “All Roads Lead To Cincinnati”
Friday, June 28, 2013

Camargo Celebrates Two 10-Year Anniversaries At Dia
Tuesday, June 04, 2013

Camargo Will Manage The Next Cardiovascular Clinical Study By Cell>Point/ Which Reported Encouraging Phase 2a Results
Wednesday, April 17, 2013

Ruth Stevens/ Ph.D. Participating Member Of The FDA Advisory Committee Meeting
Wednesday, February 13, 2013

Ken Phelps Set To Deliver Keynote Address For Eppic Annual Conference
Thursday, December 06, 2012

Camargo President To Present On The 505(b)(2) Drug Development Pathway At The 4th Chinese Pharmaceutical Industry Globalization Workshop
Tuesday, October 23, 2012

Camargo Vice President Of CMC Services Leads 505(b)(2) Roundtable And CMC Focus Group At 2012 AAPS Annual Meeting
Wednesday, October 10, 2012

Camargo Uses 505(b)(2) To Fast Track Indian Products
Tuesday, July 24, 2012

Camargo Appoints K. Gary Barnette As Vice President Of Drug Development
Tuesday, May 22, 2012

Camargo President And Vice President Lead 505(b)(2) Symposium And Cmc Focus Group At 2011 AAPS Annual Meeting
Monday, November 14, 2011

Camargo Pharmaceutical Services Announces Open House Event And Ribbon-Cutting Ceremony For New Office Location
Thursday, June 02, 2011

Camargo Expands/ Opens New Office In The Research Triangle Park
Tuesday, April 05, 2011

Camargo Expands Biologics Service Offering And Appoints Chief Medical Officer
Tuesday, January 11, 2011

Camargo’s Ruth E. Stevens Leads Open Forum At AAPS Annual Meeting
Monday, November 22, 2010

Camargo Experts To Host July Webcasts
Tuesday, June 29, 2010

Camargo Presents At The International Conference Of The Korean Society Of Pharmaceutical Services And Technology
Wednesday, December 16, 2009

Camargo Awarded For Regulatory Poster At 2009 AAPS Annual Meeting And Exposition
Tuesday, November 24, 2009

Camargo Adds VP Clinical Development & Chief Medical Officer, Samer E. Kaba, MD
Tuesday, February 03, 2009

Camargo Hires Elaine Taylor, Director Of Research Services
Wednesday, December 03, 2008

Camargo Hires Lynn Gold, Phd, Vice President Of Cmc Services
Wednesday, November 12, 2008

Camargo Hires Monica Reinhardt As Controller
Tuesday, December 04, 2007

Camargo Hires Rick Bell To Lead Business Development
Wednesday, November 28, 2007

Camargo Pharmaceutical Services Relocates To Further Its Growth
Monday, November 20, 2006

Camargo Pharmaceutical Services Enhances Team’s Expertise
Thursday, July 20, 2006

Camargo Joins Corporate Partner Program At IABG Life Sciences Solutions
Thursday, February 02, 2006